{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:18:52Z","timestamp":1764173932961},"reference-count":0,"publisher":"OMICS Publishing Group","issue":"S5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Cell Immunol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4172\/2155-9899.s5-005","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T10:38:48Z","timestamp":1363257528000},"source":"Crossref","is-referenced-by-count":3,"title":["Development of Proteasome Inhibitors as Therapeutic Drugs"],"prefix":"10.4172","volume":"01","author":[{"given":"Samuel","family":"Troy Pellom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2674","container-title":["Journal of Clinical & Cellular Immunology"],"original-title":[],"deposited":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T11:01:48Z","timestamp":1506078108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.omicsonline.org\/development-of-proteasome-inhibitors-as-therapeutic-drugs-2155-9899.S5-005.php?aid=5237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":0,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.4172\/2155-9899.s5-005","relation":{},"ISSN":["2155-9899"],"issn-type":[{"value":"2155-9899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}